Barrington Research Issues Pessimistic Forecast for Option Care Health (NASDAQ:OPCH) Stock Price

Option Care Health (NASDAQ:OPCH) had its price target reduced by Barrington Research from $40.00 to $32.00 in a report published on Thursday, Benzinga reports. They currently have an outperform rating on the stock. Barrington Research also issued estimates for Option Care Health’s Q4 2024 earnings at $0.32 EPS, Q1 2025 earnings at $0.20 EPS, Q2 2025 earnings at $0.28 EPS, Q3 2025 earnings at $0.30 EPS and Q4 2025 earnings at $0.34 EPS.

A number of other brokerages also recently issued reports on OPCH. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and dropped their price target for the stock from $38.00 to $26.00 in a research report on Thursday. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $43.00 to $29.00 in a research report on Wednesday. Finally, JMP Securities lifted their price objective on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Option Care Health has a consensus rating of “Moderate Buy” and a consensus target price of $31.60.

Option Care Health Stock Performance

NASDAQ OPCH opened at $24.11 on Thursday. The company has a market capitalization of $4.10 billion, a price-to-earnings ratio of 20.26, a PEG ratio of 1.74 and a beta of 1.32. The company has a quick ratio of 1.36, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health has a twelve month low of $22.84 and a twelve month high of $34.63. The stock has a fifty day simple moving average of $30.49 and a 200 day simple moving average of $29.91.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. The company had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.22 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. Sell-side analysts expect that Option Care Health will post 1.23 EPS for the current year.

Insider Buying and Selling at Option Care Health

In other news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares of the company’s stock, valued at $7,654,461.15. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now owns 21,339 shares in the company, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of OPCH. UMB Bank n.a. grew its holdings in Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after buying an additional 750 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after acquiring an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. boosted its position in Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after purchasing an additional 1,446 shares during the last quarter. SageView Advisory Group LLC purchased a new stake in Option Care Health during the first quarter worth about $85,000. Finally, International Assets Investment Management LLC boosted its stake in Option Care Health by 3,029.7% in the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after acquiring an additional 2,757 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.